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This daily COVID-19 Health Evidence Summary is to signpost DFID and other UK government 
departments to the latest relevant evidence and discourse on COVID-19 to inform and support 
their response. It is a result of 3 hours of work and is not intended to be a comprehensive summary 
of available evidence on COVID-19 but aims to make original documents easily accessible to 
decision makers which, if relevant to them, they should go to before making decisions.   
 
Infection Prevention and Control 
Publication 
date 
Title/URL Journal/Article 
type 
Summary             Keywords 
04.06.2020 Correlation 
between N95 
extended use 
and reuse 
and fit failure 
in an 
emergency 
department 
JAMA | 
Research 
Letter 
 There is a lack of empirical 
evidence on the 
effectiveness of N95 reuse 
and extended use during 
critical PPE shortages. This 
study examined the 
prevalence of N95 fit test 
failure while reusing 2 
common types of N95 
masks 
 Duckbill N95s had a high 
failure rate. Failure of 
dome-shaped masks was 
associated with increased 
use.  
 N95 failure may contribute 
to SARS-CoV-2 
transmission and based on 
this preliminary data, health 
systems should closely 
evaluate N95 fit during 
extended use or reuse and 
limit duckbill mask use if 
alternatives are avialable 
  
Face 
masks 
 
2 
 Limitations, including the 
study’s cross-sectional 
design, are noted 
 
Testing 
Publication 
date 
Title/URL Journal/Article 
type 
Summary             Keywords 
 04.06.2020 Serodiagnostics 
for Severe 
Acute 
Respiratory 
Syndrome-
Related 
Coronavirus-2: 
A narrative 
review 
Annals of 
Internal 
Medicine | 
Review 
 Discusses key 
use cases for 
SARS-CoV-2 
antibody 
detection tests 
and their 
application to 
serologic studies 
 Reviews 
currently 
available assays 
 Highlights 
ongoing research 
 Proposes 
potential 
strategies for test 
implementation 
 Serodiagnostics 
 
Comments, Editorials, Opinions, Blogs, News 
Publication 
date 
Title/URL Journal | Article type Author(s) 
05.06.2020 Oxford University’s COVID-19 
vaccine: next steps towards broad 
and equitable global access  
University of Oxford | 
News 
  
04.06.2020 Brazilian Health Regulatory Agency 
approves trial of Oxford COVID-19 
Vaccine 
Med Sci University of 
Oxford | News 
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05.06.2020 Retraction – Hydroxychloroquine or 
chloroquine with or without a 
macrolide for treatment of COVID-19: 
a multinational registry analysis 
The Lancet | 
Comment 
Mandeep R 
Mehra 
Frank 
Ruschitzka 
Amit N Patel 
04.06.2020 Retraction: Cardiovascular disease: 
drug therapy, and mortality in Covid-
19. NEJM DOI 
10.1056/NEJMoa2007621 
NEJM | 
Correspondence 
Mandeep R 
Mehra 
Sapan S Desai 
SreyRam Kuy 
Timothy D 
Henry 
Amit N Patel 
04.06.2020 Making decisions in a COVID-19 
world 
JAMA | Viewpoint Baruch Fischoff 
04.06.2020 Is Nigeria Ready to leave lockdown? CGD | Blog Benjamin 
Uzochukwu 
Francis Ruiz 
Kalipso 
Chalkidou 
Eno’bong Idiong 
Samantha 
Hollingworth 
04.06.2020 India’s COVID-19 testing capacity 
must grow by a factor of 10: here’s 
how that can happen 
CGD | Notes Prashant Yadav 
Abha 
Mehndiratta 
Kalipso 
Chalkidou 
Sidharth Rupani 
Krishna Reddy 
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04.06.2020 The indirect health effects of COVID-
19: lockdown measures and service 
provision 
CGD | Blog Lydia Regan 
Y-Ling Chi 
03.06.2020 As global health players pivot to 
COVID-19 responses we need 
coordinated, real-time, formative 
evaluations 
CGD | Blog Pippa Page 
Cassandra 
Nemzoff 
Kalipso 
Chalkidou 
Sam 
McPherson 
Guidelines, Statements & Tools 
Publication 
Date 
Title/URL Source   Summary 
05.06.2020 Statement from the 
Chief Investigators of 
the Randomised 
Evaluation of COVid-
19 thERapY 
(RECOVERY) Trial 
on 
hydroxychloroquine 
RECOVERY 
Trial | 
Statement  
 At the request of the MHRA the 
independent DMC 
recommended chief 
investigators review the 
unblinded data on the 
hydroxychloroquine arm of the 
trial 
 No clinical benefit from use of 
hydroxychloroquine in 
hospitalised patients with 
COVID-19 
 Participants are no longer to be 
enrolled to the 
hydroxychloroquine arm of the 
RECOVERY trial with 
immediate effect 
 Full results will be made 
available as soon as possible 
01.06.2020 Maintaining essential 
health services: 
operational guidance 
for the COVID-19 
context 
WHO | Interim 
guidance 
 Note an update to interim 
guidance issues on 25 March 
2020 
 Practical actions that countries 
can take at national, 
subregional and local levels to 
reorganise and safely delivery 
high-quality essential health 
services in the pandemic 
context 
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 Includes sample indicators for 
monitoring essential health 
services  
 Describes considerations when 
to stop and restart services as 
C19 transmission recedes and 
surges 
May 2020 COVID-19 
Considerations for 
home and 
community-based 
care 
SSHAP | Brief 
 Guidelines from LMICs 
recognise the need for 
supported home and 
community-based care for C19 
to protect formal healthcare 
setting capacity and to reduce 
the risk of spread in health 
facilities. Moreover, not all will 
be able to access services or 
may prefer home care. 
 The Brief reviews existing 
guidance n home and 
community-based care for C19 
in different contexts, identifies 
key issues and offers 
recommendations for 
addressing gaps in home and 
community-based care 
Dashboards & Trackers 
Cases & 
deaths: 
Global 
Cases & 
deaths: 
Regional 
Cases & 
deaths: 
Country 
Living 
evidence & 
policy maps 
Current 
research 
including trials 
  Diagnostics  Treatments   Vaccines 
WHO sitreps WHO 
Africa 
Ghana COVID-
NMA 
WHO   FIND 
SARS-CoV-
2 Test 
Tracker 
  Global 
COVID-19 
Clinical Trial 
Tracker 
  CEPI 
WHO 
dashboard 
African 
Arguments 
Indonesia EPPI 
Centre 
WHO 
International 
Clinical Trials 
Registry 
Platform 
(ICTRP) 
 FIND 
SARS-CoV-
2 
Diagnostics: 
performance 
data 
  US NIH 
registered 
clinical trials 
Vaccine 
Centre 
LSHTM 
Johns 
Hopkins 
University 
European 
CDC 
Nigeria 
CDC 
Norwegian 
Institute of 
Public 
Health 
Cytel  Serology-
based tests 
for COVID-
19 
  Solidarity 
trial 
 COVID-
19 Oxford 
Vaccine 
Trial 
6 
WEF 
  Sierra 
Leone 
 Oxford C19 
Government 
Response 
Tracker 
(OxCGRT) 
US NIH  Our World 
in Data: C19 
Testing 
  COVID-19 
Therapeutics 
Accelerator 
  
Our World in 
Data 
  Singapore  Our World 
in Data: 
C19 Policy 
responses 
COVID-
evidence 
      
Global 5050 
  UK  IFPRI 
COVID-19 
Policy 
Response 
Portal 
Cochrane       
CEBM, 
University of 
Oxford 
  US  COVID-19 
Primer 
Clinicaltrials.gov       
Humanitarian 
Data 
Exchange 
     NIH 
LitCovid 
 UKCDR       
Information 
is Beautiful 
     WHO 
COVID-19 
Database 
        
LSHTM               
HealthMap 
(cases) 
              
The 
Commons 
Project 
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C19 Resource Hubs 
Global  Regional & 
Country 
Academic 
journals & 
Publishers 
Institutes/Centres/Funders/Other Health 
Topics 
  Social 
Sciences 
WHO COVID-
19 pandemic  
Africa CDC Annals of 
Internal 
Medicine 
LSTM Stop TB 
Partnership 
  SSHAP 
WHO risk 
communication 
African 
Union 
BMJ LSHTM 
 
  IDA 
WHO Q&A Nigeria 
CDC 
Bulletin of 
the WHO 
ICL MRC Centre for Global 
Infectious Disease Analysis  
Global 
Menstrual 
Collective  
  Disability 
and 
inclusion 
WHO Global 
research 
GeoPoll: 
SSA 
Cambridge 
University 
Press 
ODI SLH: 
Handwashing 
in low 
resource 
settings 
  Coregro
up IDDC 
COVID-19 
Solidarity 
Response Fund 
Global 
Health 
Network 
Africa 
Cell Press Johns Hopkins University RBM 
Partnership 
  Ethics, 
health 
systems 
& COVID-
19 
UN African 
Academy of 
Sciences 
Cochrane  Center for Global Development      Social 
Developm
ent Direct 
C19 blog 
series 
UN Women Africa 
Evidence 
Network 
Elsevier CMMID Repository     
UNOCHA OCHA 
Southern 
and Eastern 
Africa 
JAMA 
Network 
Norwegian Institute of Public 
Health 
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COVID-19 
Digest 
UNHCR  South 
African 
Government 
The 
Lancet 
Oxford Centre for Evidence-
based Medicine 
    
UNICEF   medRxiv 
and 
bioRxiv 
(Preprints) 
 HEART     
UNESCO   NEJM  UKRI     
UN WFP   Oxford 
University 
Press 
 Evidence Aid     
GOARN   PLoS  NIH     
EPI-WIN   SAGE 
journals 
IFPRI Resources and Analyses 
of C19 Impact 
    
World Bank   Science  Prevent Epidemics      
Our World in 
Data 
  Springer 
Nature 
      
COVID-19 
Narratives by 
David Nabarro 
  SSRN 
(Preprints)  
      
Reliefweb   Wiley       
Humanitarian 
OpenStreetMap 
Team 
          
Global 
Partnership for 
Sustainable 
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Development 
Data 
WorldPop           
Flowminder           
COVID-END           
Premise 
COVID-19 
Global Impact 
Study 
    
  
Online learning & events 
Date Title/URL Online 
learning/event 
Duration Lead 
Available 
now 
Standard precautions: 
Environmental 
cleaning and 
disinfection 
Online course 1 hour WHO 
16.06.2020 Africa beyond COVID-
19 
Virtual event 1h 30 
hours 
ODI 
15.06.2020 Poverty monitoring in 
the context of Covid-
19 
Virtual event 1h 15 ODI 
Available 
now 
COVID-19: Effective 
Nursing in Times of 
Crisis 
Online course 2 weeks – 
2 hours per 
week 
Johns Hopkins School 
of Nursing 
05.06.2020 
12pm ET 
CGD Conversations 
on COVID-19 and 
Development: John 
Nkengasong 
Event   CGD 
10 
Available 
now 
WHO Academy and 
WHO Info mobile 
applications 
Mobile app   WHO 
Available 
now 
COVID-19: 
Pandemics, Modelling 
and Policy 
Online 
learning 
2 weeks | 2 
hours 
weekly 
study 
FutureLearn UNESCO 
UNITWIN Complex 
Systems Digital 
Campus/Open 
University 
12.05.2020 COVID-19 and 
maintaining quality 
essential health 
services  
Webinar 1 hour WHO & ISQua – Dr 
Shams Syed, Dr Peter 
Lachman, Dr Teri 
Rynolds & Dr Ed Kelley 
11.5.2020 COVID-19 Contact 
Tracing course 
Online 
learning 
5 hours Johns Hopkins 
Bloomberg School of 
Health 
7-28 May 
2020 
Virtual Evidence 
Weeks 
5 sessions 1h 30 International Initiative 
for Impact Evaluation 
(3ie) 
Tuesdays at 
1700 CEST 
(Geneva 
time) & 
Thursdays 
0830 CEST 
(Geneva 
time) 
COVID-19 Open 
online brief with Dr 
David Nabarro 
Event 1h 4SD 
30.04.2020 Professor Chris 
Whitty’s Gresham 
lecture on COVID-19 
Event 1h 20 Gresham College 
Available 
now 
Emerging respiratory 
viruses, including 
COVID-19: methods 
for detection, 
prevention, response 
and control 
Online 
learning 
3 hours WHO 
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Available 
now 
Responding to 
COVID-19: Real-time 
training for the 
coronavirus disease 
outbreak 
Online 
learning 
Multiple 
self-paced 
course 
WHO 
25 May 
2020 
COVID-19: Tackling 
the Novel Coronavirus 
Online 
learning 
3 weeks | 4 
hours 
weekly 
study 
FutureLearn 
LSHTM/UK PHRST 
Available 
online now 
without 
mentors. 
Updated 
version will 
commence 
early June 
2020 
COVID-19 
Diagnostics and 
Testing 
Online 
learning 
3 weeks | 3 
hours 
weekly 
study 
FutureLearn 
FIND/LSHTM/ASLM 
6 April 2020 COVID-19 Critical 
Care: Understanding 
and Application 
Online 
learning 
5 weeks | 1 
hour 
weekly 
study 
FutureLearn University 
of Edinburgh & Royal 
College of Physicians 
of Edinburgh  
Available 
now 
COVID-19 supporting 
online courses 
Online 
learning 
Multiple 
self-paced 
course 
BMJ Learning 
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Rapid review methodology 
The rapid daily search for peer-reviewed literature is carried out through a PubMed search with the following 
keywords (“COVID-19” OR “severe acute respiratory syndrome coronavirus 2” OR “2019-nCoV” OR “SARS-CoV-
2” OR “2019nCoV” OR “coronavirus” ) AND (“Africa”) OR (“equity” OR “equities”) OR (“poverty”), restricted to 
articles published in the previous 2 to 3 days, in English. This is complemented by a search of the homepage of 
the following high-impact global health journals: The Lancet journals, New England Journal of Medicine, Nature, 
JAMA, Annals of Internal Medicine, Cochrane Reviews, BMJ Global Health, the PLoS journals and a Twitter 
search of their Twitter pages. A search also of preprints from bioRxiv and medRxiv. Please note that papers that 
have not been peer-reviewed are highlighted in red. All primary research papers that relate to the primary and 
secondary impacts of the COVID-19 response in LMICs, and disease control and health system responses are 
included. Articles related to tackling the secondary impacts on other sectors are not included. Additional 
commentaries, opinions, and commissioned pieces are selected based on relevance. 
The search for dashboards, guidelines, tools, editorials, comments, blogs, opinions and news is through the 
academic journals listed above, C19 resource hubs and following lead academics and professionals on Twitter. 
About this report 
This daily COVID-19 health evidence summary (HES) is based on 3 hours of desk-based research. The 
summary is not intended to be a comprehensive summary of available evidence on COVID-19 but aims to make 
original documents easily accessible to decision makers which, if relevant to them, they should go to before 
making decisions. The HES are not intended to replace medical or professional advice and the researcher or the 
K4D consortium cannot be held responsible for any decisions made about COVID-19 on the basis of the HES 
alone. K4D services are provided by a consortium of leading organisations working in international development, 
led by the Institute of Development Studies (IDS), with Education Development Trust, Itad, University of Leeds 
Nuffield Centre for International Health and Development, Liverpool School of Tropical Medicine (LSTM), 
University of Birmingham International Development Department (IDD) and the University of Manchester 
Humanitarian and Conflict Response Institute (HCRI). 
This evidence summary was prepared for the UK Government’s Department for 
International Development (DFID) and its partners in support of pro-poor programmes. 
It is licensed for non-commercial purposes only. K4D cannot be held responsible for 
errors, omissions or any consequences arising from the use of information contained in 
this health evidence summary. Any views and opinions expressed do not necessarily 
reflect those of DFID, K4D or any other contributing organisation.  
© DFID - Crown copyright 2020. 
 
